Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2009, Vol. 3 Issue (4) : 396-402     DOI: 10.1007/s11684-009-0056-z
Research articles |
Construction and expression of hepatitis B virus vector encoding TC-tagged core protein
Yuanyuan LIN MD1,Xiaoming CHENG MS1,Yuhu SONG MD1,Peiyuan LI MD1,Ying CHANG MM1,Jinjian YAO MD1,Jusheng LIN MD, PhD1,Li ZHOU PhD2,Leiming XU PhD3,
1.Institute of Liver Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; 2.Department of Neurobiology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; 3.Department of Pathophysiology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;
Download: PDF(183 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  Virus tagged with green fluorescent protein (GFP) contributes to the visualization and study of the virus in living cells. However, the hepatitis B virus (HBV) particle, which is a compact virion with limited internal space, cannot be incorporated with GFP tag as a large fragment. It was recently reported that protein genetically inserted with a smaller size tetracysteine (TC) tag could be specially labeled by a biarsenical fluorescent dye in living cells. In this study, we constructed a recombinant HBV vector encoding TC-tagged core protein for biarsenical labeling of HBV virion. TC tag was genetically inserted near the immunodominant c/e1 site of HBV core protein by mutagenesis. Western blot and enzyme-linked immunosorbent assay (ELISA) analysis showed that the TC-tagged core protein, hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) could be expressed in cells transfected with the recombinant HBV vector, which is similar to the cells transfected with wild-type HBV vector. Reverse transcription-polymerase chain reaction (RT-PCR) and Southern blot analysis showed that HBV virion formation was affected by the genetic insertion of TC tag into core protein in some degree, but cells transfected with the HBV vector could still produce HBV virions incorporated with TC-tagged core proteins. Taken together, the recombinant HBV vector can serve as a useful tool to produce HBV virions incorporated with TC-tagged core proteins to be fluorescently labeled by biarsencial dye for visualizing and studying HBV in living cells.
Keywords hepatitis B virus      vector      tetracysteine tag      core protein      
Issue Date: 05 December 2009
URL:  
http://academic.hep.com.cn/fmd/EN/10.1007/s11684-009-0056-z     OR     http://academic.hep.com.cn/fmd/EN/Y2009/V3/I4/396
Ganem D, Prince A M. Hepatitis B virus infection-naturalhistory and clinical consequences. N EnglJ Med, 2004, 350(11): 1118―1129

doi: 10.1056/NEJMra031087
Seeger C, Mason W S. Hepatitis B virus biology. Microbiol Mol Biol Rev, 2000, 64(1): 51―68

doi: 10.1128/MMBR.64.1.51-68.2000
Greber U F, Way M. A superhighway to virus infection. Cell, 2006, 124(4): 741―754

doi: 10.1016/j.cell.2006.02.018
Campbell E M, Perez O, Melar M, Hope T J. LabelingHIV-1 virions with two fluorescent proteins allows identificationof virions that have productively entered the target cell. Virology, 2007, 360(2): 286―293

doi: 10.1016/j.virol.2006.10.025
Le L P, Le H N, Nelson A R, Matthews D A, Yamamoto M, Curiel D T. Core labeling of adenovirus with EGFP. Virology, 2006, 351(2): 291―302

doi: 10.1016/j.virol.2006.03.042
Lux K, Goerlitz N, Schlemminger S, Perabo L, Goldnau D, Endell J, Leike K, Kofler D M, Finke S, Hallek M, Buning H. Green fluorescent protein-tagged adeno-associated virus particlesallow the study of cytosolic and nuclear trafficking. J Virol, 2005, 79(18): 11776―11787

doi: 10.1128/JVI.79.18.11776-11787.2005
McDonald D, Vodicka M A, Lucero G, Svitkina T M, Borisy G G, Emerman M, Hope T J. Visualizationof the intracellular behavior of HIV in living cells. J Cell Biol, 2002, 159(3): 441―452

doi: 10.1083/jcb.200203150
Sampaio K L, Cavignac Y, Stierhof Y D, Sinzger C. Human cytomegalovirus labeled with green fluorescent protein forlive analysis of intracellular particle movements. J Virol, 2005, 79(5): 2754―2767

doi: 10.1128/JVI.79.5.2754-2767.2005
Smith G A, Pomeranz L, Gross S P, Enquist L W. Local modulation of plus-end transport targets herpesvirus entryand egress in sensory axons. Proc NatlAcad Sci U S A, 2004, 101(45): 16034―16039

doi: 10.1073/pnas.0404686101
Griffin B A, Adams S R, Tsien R Y. Specific covalent labeling of recombinant protein moleculesinside live cells. Science, 1998, 281(5374): 269―272

doi: 10.1126/science.281.5374.269
Adams S R, Campbell R E, Gross L A, Martin B R, Walkup G K, Yao Y, Llopis J, Tsien R Y. New biarsenical ligands and tetracysteine motifs forprotein labeling in vitro and in vivo: synthesis and biological applications. J Am Chem Soc, 2002, 124(21): 6063―6076

doi: 10.1021/ja017687n
Gaietta G, Deerinck T J, Adams S R, Bouwer J, Tour O, Laird D W, Sosinsky G E, Tsien R Y, Ellisman M H. Multicolor and electron microscopic imaging of connexin trafficking. Science, 2002, 296(5567): 503―507

doi: 10.1126/science.1068793
Panchal R G, Ruthel G, Kenny T A, Kallstrom G H, Lane D, Badie S S, Li L, Bavari S, Aman M J. In vivo oligomerization and raft localization of Ebola virus proteinVP40 during vesicular budding. Proc NatlAcad Sci U S A, 2003, 100(26): 15936―15941

doi: 10.1073/pnas.2533915100
Rudner L, Nydegger S, Coren L V, Nagashima K, Thali M, Ott D E. Dynamic fluorescent imaging of human immunodeficiencyvirus type 1 gag in live cells by biarsenical labeling. J Virol, 2005, 79(7): 4055―4065

doi: 10.1128/JVI.79.7.4055-4065.2005
Kratz P A, Bottcher B, Nassal M. Native display of complete foreign protein domains onthe surface of hepatitis B virus capsids. Proc Natl Acad Sci U S A, 1999, 96(5): 1915―1920

doi: 10.1073/pnas.96.5.1915
Beterams G, Bottcher B, Nassal M. Packaging of up to 240 subunits of a 17 kDa nucleaseinto the interior of recombinant hepatitis B virus capsids. FEBS Lett, 2000, 481(2): 169―176

doi: 10.1016/S0014-5793(00)01927-X
Vogel M, Vorreiter J, Nassal M. Quaternary structure is critical for protein displayon capsid-like particles (CLPs): efficient generation of hepatitisB virus CLPs presenting monomeric but not dimeric and tetrameric fluorescentproteins. Proteins, 2005, 58(2): 478―488

doi: 10.1002/prot.20312
Ponsel D, Bruss V. Mapping of amino acid sidechains on the surface of hepatitis B virus capsids required for envelopmentand virion formation. J Virol, 2003, 77(1): 416―422

doi: 10.1128/JVI.77.1.416-422.2003
Guidotti L G, Matzke B, Schaller H, Chisari F V. High-level hepatitis B virus replication in transgenic mice. J Virol, 1995, 69(10): 6158―6169
Schildgen O, Sirma H, Funk A, Olotu C, Wend U C, Hartmann H, Helm M, Rockstroh J K, Willems W R, Will H, Gerlich W H. Variant of hepatitis B virus with primary resistanceto adefovir. N Engl J Med, 2006, 354(17): 1807―1812

doi: 10.1056/NEJMoa051214
Guarnieri M, Kim K H, Bang G, Li J, Zhou Y, Tang X, Wands J, Tong S. Point mutations upstream of hepatitis B virus core geneaffect DNA replication at the step of core protein expression. J Virol, 2006, 80(2): 587―595

doi: 10.1128/JVI.80.2.587-595.2006
Locarnini S, Shaw T, Dean J, Colledge D, Thompson A, Li K, Lemon S M, Lau G G, Beard M R. Cellular response to conditional expression of the hepatitis B virusprecore and core proteins in cultured hepatoma (Huh-7) cells. J Clin Virol, 2005, 32(2): 113―121

doi: 10.1016/j.jcv.2004.10.002
Lei Y C, Hao Y H, Zhang Z M, Tian Y J, Wang B J, Yang Y, Zhao X P, Lu M J, Gong F L, Yang D L. Inhibition of hepatitis B virus replicationby APOBEC3G in vitro and in vivo. WorldJ Gastroenterol, 2006, 12(28): 4492―4497
Zhou X M, Lin J S, Shi Y, Tian D A, Huang H J, Zhou H J, Jin Y X. Establishment of a screeningsystem for selection of siRNA target sites directed against hepatitisB virus surface gene. Acta Biochim BiophysSin (Shanghai), 2005, 37(5): 310―316

doi: 10.1111/j.1745-7270.2005.00049.x
Delaney W E 4th, Isom H C. Hepatitis B virus replicationin human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology, 1998, 28(4): 1134―1146

doi: 10.1002/hep.510280432
Le Seyec J, Chouteau P, Cannie I, Guguen-Guillouzo C, Gripon P. Infection process of thehepatitis B virus depends on the presence of a defined sequence inthe pre-S1 domain. J Virol, 1999, 73(3): 2052―2057
Bruss V. Envelopment of the hepatitis B virus nucleocapsid. Virus Research, 2004, 106(2): 199―209

doi: 10.1016/j.virusres.2004.08.016
Koschel M, Oed D, Gerelsaikhan T, Thomssen R, Bruss V. Hepatitis B virus core genemutations which block nucleocapsid envelopment. J Virol, 2000, 74(1): 1―7

doi: 10.1128/JVI.74.1.1-7.2000
Tong S. Mechanism of HBV genome variability and replication of HBV mutants. J Clin Virol, 2005, 34Suppl1: S134―138

doi: 10.1016/S1386-6532(05)80023-X
Ahn S H, Kramvis A, Kawai S, Spangenberg H C, Li J, Kimbi G, Kew M, Wands J, Tong S. Sequence variation upstream of precore translation initiation codonreduces hepatitis B virus e antigen production. Gastroenterology, 2003, 125(5): 1370―1378

doi: 10.1016/j.gastro.2003.07.016
Bruss V. Hepatitis B virus morphogenesis. WorldJ Gastroenterol, 2007, 13(1): 65―73
[1] Yong-Yuan Zhang,Ke-Qin Hu,Zhongping Duan. New perspective on the natural course of chronic HBV infection[J]. Front. Med., 2014, 8(2): 129-134.
[2] Du Yan, Han Xue, Pu Rui, Xie Jiaxin, Zhang Yuwei, Cao Guangwen. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk[J]. Front. Med., 2014, 8(2): 217-226.
[3] Jia-Xin XIE, Jian-Hua YIN, Qi ZHANG, Rui PU, Wen-Ying LU, Hong-Wei ZHANG, Guang-Wen CAO, Jun ZHAO, Hong-Yang WANG, . Association of novel mutations and heplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma[J]. Front. Med., 2010, 4(4): 419-429.
[4] Lei CHEN, Liang HU, Liang LI, Yuan LIU, Qian-Qian TU, Yan-Xin CHANG, He-Xin YAN, Meng-Chao WU, Hong-Yang WANG, . Dysregulation of β-catenin by hepatitis B virus X protein in HBV-infected human hepatocellular carcinomas[J]. Front. Med., 2010, 4(4): 399-411.
[5] Hong-Zhu LU MD, Dan LIU BM, Qi-Hong FAN BM, Jian-Hua ZHOU MD, . Hepatitis B virus X protein upregulates tumor necrosis factor-α expression of rat mesangial cell line via ERKs pathway[J]. Front. Med., 2010, 4(1): 106-111.
[6] Li-Feng LIU MD, PhD, Qiong CHEN MD, PhD, Ying CHANG MD, PhD, Ju-Sheng LIN MD, PhD, Jin-Liang ZHANG MM, . Cyclooxygenase-2 gene-1195G/A genotype is associated with the risk of HBV-induced HCC: A case-control study in Han Chinese people[J]. Front. Med., 2010, 4(1): 90-95.
[7] Feng JIANG PhD , Xuezhen WANG PhD , Zheng XUE MD , Suming ZHANG PhD , Siyu FANG BM , Min ZHANG MD, PhD , . Lentivector-mediated RNAi efficiently downregulates expression of murine cdk4 gene [J]. Front. Med., 2009, 3(3): 287-291.
[8] Fanghe LI BM , Chunyan ZHANG MS , Jinghua LIU MS , Xiaoyan ZHANG MS , Bing YAN , Bo ZHANG MS , Yongguo HUANG MS , Jingsong GONG BM , Yan CHEN BM , . Preparation, identification, and clinical application of anti-HBs monoclonal antibody that binds both wild-type and immune escape mutant HBsAgs[J]. Front. Med., 2009, 3(3): 277-283.
[9] Gang LI MD , Xiaojia XIONG MM , . MicroRNAs and hepatitis viruses[J]. Front. Med., 2009, 3(3): 265-270.
[10] Zhengjuan LIU, Jie BIAN, Yuchuan WANG, Yongli ZHAO, Dong YAN, Xiaoxia WANG. Construction and identification of lentiviral RNA interference vector of rat leptin receptor gene[J]. Front Med Chin, 2009, 3(1): 57-60.
[11] SHA Yugen, HUANG Songming, ZHANG Aihua, ZHAO Fei, CHEN Ronghua. Effects of podocin transfection on CD2AP distribution in HEK293 cells[J]. Front. Med., 2008, 2(1): 35-38.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed